|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
8-9
|
|
pubmed:dateCreated |
1998-2-24
|
|
pubmed:abstractText |
The cardiac isoform of troponin I (cTnI) is a myofibrillar protein highly specific for myocardial injury. We used a recently developed new-generation immunoassay with high analytical sensitivity to measure cTnI in patients diagnosed with hematologic malignancies, before chemotherapy and after an intermediate cumulative dose of anthracyclines. We hypothesized that measurement of cTnI with this sensitive method would provide evidence of myocardial injury in these patients.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:issn |
0954-6928
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
8
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
537-41
|
|
pubmed:dateRevised |
2004-11-17
|
|
pubmed:meshHeading |
pubmed-meshheading:9431482-Adult,
pubmed-meshheading:9431482-Aged,
pubmed-meshheading:9431482-Antibiotics, Antineoplastic,
pubmed-meshheading:9431482-Biological Markers,
pubmed-meshheading:9431482-Cardiomyopathies,
pubmed-meshheading:9431482-Creatine Kinase,
pubmed-meshheading:9431482-Dose-Response Relationship, Drug,
pubmed-meshheading:9431482-Female,
pubmed-meshheading:9431482-Heart,
pubmed-meshheading:9431482-Hematologic Neoplasms,
pubmed-meshheading:9431482-Humans,
pubmed-meshheading:9431482-Male,
pubmed-meshheading:9431482-Middle Aged,
pubmed-meshheading:9431482-Myoglobin,
pubmed-meshheading:9431482-Radioimmunoassay,
pubmed-meshheading:9431482-Sensitivity and Specificity,
pubmed-meshheading:9431482-Stroke Volume,
pubmed-meshheading:9431482-Troponin I
|
|
pubmed:articleTitle |
Cardiac troponin I in patients with hematologic malignancies.
|
|
pubmed:affiliation |
Department of Cardiology, INSERM U-390, Montpellier, France.
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Controlled Clinical Trial
|
